Exome sequencing of patients with extreme toxicities to uncover pharmacogenomics of 5-fluorouracil-based chemotherapeutics in colorectal cancer

被引：0

作者：

Simoes, Ana ^{[1
]}

Lopez Doldan, Carmen ^{[2
]}

Duran-Pineiro, Goretti ^{[1
]}

Fernandez-Montes, Ana ^{[3
]}

Garcia-Gomez, Jesus ^{[3
]}

Fernandez-Gonzalez, Maria Perfecta ^{[2
]}

Salgado-Fernandez, Mercedes ^{[3
]}

Paez, David ^{[4
,5
,6
]}

Guino, Elisabet ^{[7
]}

Lopez-Fernandez, Luis ^{[8
]}

Rojas, Augusto ^{[9
]}

Castells, Antoni ^{[10
]}

Castellvi-Bel, Sergi ^{[10
]}

Ruiz-Ponte, Clara ^{[1
,11
]}

Vymetalkova, Veronika ^{[12
]}

Vodicka, Pavel ^{[12
]}

Garcia de Santiago, Belen ^{[13
]}

Lopez-Aspiroz, Elena ^{[13
]}

Garcia-Mata, Jesus ^{[3
]}

Carracedo, Angel ^{[1
,11
]}

Fernandez-Rozadilla, Ceres ^{[1
]}

机构：

[1] Inst Invest Sanitaria Santiago, Santiago De Compostela, Spain

[2] Complexo Hosp Univ Ourense, Oncol Pharm, Orense, Spain

[3] Complexo Hosp Univ Ourense, Oncol, Orense, Spain

[4] Hosp Santa Creu & Sant Pau, Barcelona, Spain

[5] Med Sci Innovat Res, Barcelona, Spain

[6] Univ Autonoma Barcelona, Barcelona, Spain

[7] Inst Catala Oncol, Barcelona, Spain

[8] Hosp Gen Univ Gregorio Maranon, Dept Pharm, Madrid, Spain

[9] Tecnol Monterrey, Sch Med & Hlth Sci, Monterrey, Mexico

[10] Inst Invest Biomed August Pi & Sunyer, Dept Gastroenterol, Barcelona, Spain

[11] Fdn Publ Galega Med Xenom, Santiago De Compostela, Spain

[12] Charles Univ Prague, Inst Biol & Med Genet, Prague, Czech Republic

[13] Hosp Univ Infanta Sofia, Hosp Pharm Serv, Madrid, Spain

来源：

EUROPEAN JOURNAL OF HUMAN GENETICS | 2023年 / 31卷

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

EP19.003

引用

页码：300 / 300

页数：1

共 50 条

[1] The dihydrouracil/uracil ratios in plasma and toxicities of 5-fluorouracil-based adjuvant chemotherapy in colorectal cancer patients
Zhou, Zhi Wei
Wang, Guo Qiang
Wan, De Sen
Lu, Zhen Hai
Chen, Ying Bo
Li, Su
Chen, Gong
Pan, Zhi Zhong
CHEMOTHERAPY, 2007, 53 (02) : 127 - 131
[2] IDENTIFICATION OF PHARMACOGENOMIC MARKERS OF 5-FLUOROURACIL-BASED CHEMOTHERAPY IN COLORECTAL CANCER
Mini, Enrico
Nobili, Stefania
Napoli, Cristina
Landini, Ida
Morganti, Maria
Cianchi, Fabio
Valanzano, Rosa
Tonelli, Francesco
Mazzei, Teresita
ANNALS OF ONCOLOGY, 2009, 20
[3] 5-Fluorouracil-based chemotherapy for colorectal cancer and MTHFR/MTRR genotypes
Pardini, Barbara
Kumar, Rajiv
Naccarati, Alessio
Novotny, Jan
Prasad, Rashmi B.
Forsti, Asta
Hemminki, Kari
Vodicka, Pavel
Bermejo, Justo Lorenzo
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 72 (01) : 162 - 163
[4] Is repeated treatment with a 5-fluorouracil-based regimen useful in colorectal cancer?
Goldberg, RM
SEMINARS IN ONCOLOGY, 1998, 25 (05) : 21 - 28
[5] Cost Analysis of Capecitabine vs 5-Fluorouracil-Based Treatment for Metastatic Colorectal Cancer Patients
De Portu, S.
Mantovani, L. G.
Ravaioli, A.
Tamburini, E.
Bollina, R.
Cozzi, C.
Grimaldi, A. M.
Testa, T. E.
Bianchessi, C.
Carteni, G.
JOURNAL OF CHEMOTHERAPY, 2010, 22 (02) : 125 - 128
[6] Amplification of thymidylate synthetase in metastatic colorectal cancer patients pretreated with 5-fluorouracil-based chemotherapy
Watson, Roshawn G.
Muhale, Filipe
Thorne, Leigh B.
Yu, Jinsheng
O'Neil, Bert H.
Hoskins, Janelle M.
Meyers, Michael O.
Deal, Allison M.
Ibrahim, Joseph G.
Hudson, Michael L.
Walko, Christine M.
McLeod, Howard L.
Auman, James T.
EUROPEAN JOURNAL OF CANCER, 2010, 46 (18) : 3358 - 3364
[7] SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer
Boulay, JL
Mild, G
Lowy, A
Reuter, J
Lagrange, M
Terracciano, L
Laffer, U
Herrmann, R
Rochlitz, C
BRITISH JOURNAL OF CANCER, 2002, 87 (06) : 630 - 634
[8] SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer
J-L Boulay
G Mild
A Lowy
J Reuter
M Lagrange
L Terracciano
U Laffer
R Herrmann
C Rochlitz
British Journal of Cancer, 2002, 87 : 630 - 634
[9] Lactose Intolerance Associated With Adjuvant 5-Fluorouracil-Based Chemotherapy for Colorectal Cancer
Osterlund, Pia
Ruotsalainen, Tarja
Peuhkuri, Katri
Korpela, Riitta
Ollus, Anneli
Ikonen, Minna
Joensuu, Heikki
Elomaa, Inkeri
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (08) : 696 - 703
[10] Erratum: SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer
J-L Boulay
G Mild
A Lowy
J Reuter
M Lagrange
L Terracciano
U Laffer
R Herrmann
C Rochlitz
British Journal of Cancer, 2003, 89 : 422 - 422

← 1 2 3 4 5 →